Table 3.
Thrombocytopenia and thromboembolic events on ECMO support.
| Platelet on admission (cells/μl) | 567,000 | 239,000 | 218,000 |
| ECMO type | V-V | V-V | V-V |
| Time of ECMO initiation since admission | Day 2 | Day 5 | Day 2 |
| Platelet level on first day of ECMO (cells/μl) | 462,000 | 153,000 | 177,000 |
| Initiation of anticoagulation | Day 1 | Day 1 | Day 1 |
| Time of development of thrombocytopenia since admission | Day 30 | Day 7 | Day 34 |
| Platelet nadir (cells/μl) | 52,000 | 61,000 | 30,000 |
| Time of thromboembolism development since admission | Day 3 | Day 5 | Day 3 |
| Type of thromboembolism | Multiple DVT, diagnoses by venous ultrasound | PE, diagnosed by chest CTA | Multiple DVT, diagnosed by venous ultrasound |
| Hemorrhage requiring transfusion | Yes (day 26) | Yes (day 44) | No |
| Site of bleeding | Gastrointestinal tract | Hemothorax | None |
| ECMO circuit thrombosis | No | No | No |
| HIT | No | No | No |
| Stroke | No | No | No |
| Total ECMO days | 52 | 23 | 22 |
| Hospital days of stay | 53 | 58 | 38 |
| Outcome | Deceased | Discharged | Discharged |
| Cause of death | Asystole | None | None |